Meet our Leadership team

RMS is led by a team of physician-scientists, researchers, and business executives with decades of combined experience in transplant surgery, stem cell biology, and company building. This includes the surgeon-scientist behind our core stem cell technology and the founder executive who built and sold a $50M analytics company.

Dr. Jon S. Odorico, MD, FACS, is the Scientific Founder of Regenerative Medical Solutions. He is responsible for the overall scientific direction of the Company. Dr. Odorico is also a Professor, Department of Surgery in the Division of Organ Transplantation at the University of Wisconsin-Madison School of Medicine and Public Health in Madison, WI. Dr. Odorico is certified by the American Board of Surgery and specializes in pancreas transplants, islet cell transplants and multi-organ transplants. In addition, he performs general surgery procedures on transplant patients. He currently serves as Director of both the Pancreas and Islet Transplantation Programs. He received his B.S. in Chemistry from Duke University in 1983 and his medical degree from New York University, School of Medicine in 1987. He then completed training in General Surgery and Transplantation at the University of Pennsylvania and the University of Wisconsin, respectively.

Jon S. Odorico, MD, FACS

Scientific Founder

He has received numerous awards in his research field of study, including the National Research Service Award from the National Institutes of Health, the Jonathon E. Rhoads Research Award from the Harrison Department of Surgical Research, at University of Pennsylvania School of Medicine, the Best Abstract Award from OrthoBiotech Transplant Fellows Workshop, Howard Hughes Medical Institute Faculty Development Award, the Vilas Associate Award from the University of Wisconsin and the Fujisawa Faculty Development Award from American Society of Transplant Surgeons. With more than 20 years in stem cell and diabetes research, he is a key thought leader in the field, as evidenced by numerous peer-reviewed publications and book chapters, as well as service on grant review boards. Dr. Odorico co-authored the textbook Human Embryonic Stem Cells (Taylor and Francis, 2005). Over the years he has worked with Dr. James Thomson, the University of Wisconsin stem cell pioneer, collaborating with him on grants and publications. Dr. Odorico is also a member of the Stem Cell and Regenerative Medicine Center at the University of Wisconsin and regularly collaborates with many stem cell scientists worldwide.

Anthony D. Kolton:

President and CEO

Anthony (Tony) D. Kolton is President and the business Founder of RMS. Mr. Kolton has had extensive experience and a successful track record in both start-ups and technology companies. He founded Logical Information Machines (LIM) in 1988 with three other partners, each putting up $1,000 in capital (for a total $4,000 in capital) and, under his direction as President, turned the company into a business with revenues over $20 million per year. At LIM, he also invented the “Market Information Machine”, a tool that allows you to ask any question about any market and obtain an instant answer, which became the company’s flagship product. In December 2009, LIM was sold to Morningstar for over $50 million.

Mr. Kolton earned a Bachelor of Science degree in Accounting from DePaul University and subsequently his CPA certificate. He also earned both a Masters in Taxation degree and a Juris Doctor degree in law from DePaul University, after attending both programs simultaneously at night.

Dr. Dena E. Cohen, PhD, ALM, is the Chief Scientific Officer of RMS. She is responsible for direction of RMS’s research program, oversees the research team, and leads product and process development for the company. Dr. Cohen received her B.S. degree from the Massachusetts Institute of Technology in the field of biology in 1998, and a PhD degree from Harvard University in the field of genetics in 2005. She subsequently completed a Master of Liberal Arts degree in the field of management at the Harvard University Extension School. Her scientific research has been published in a variety of prestigious journals including Genes & Development, Developmental Cell, Nature Medicine, and the Journal of the American Society of Nephrology.

Dena E Cohen, PhD, ALM

Chief Scientific Officer

Thomas P. Joyce is Vice President of Corporate Development and Administration at Regenerative Medical Solutions. In this role he manages day-to-day operations of finance, marketing and logistics for RMS. He previously served as a key market researcher with Logical Information Machines specializing in developing data, conducting research and streamlining financial operations. Mr. Joyce was named to the Dean’s List in all semesters and graduated Summa Cum Laude with a degree in Finance and Banking from the Trulaske College of Business at the University of Missouri-Columbia.

Thomas P. Joyce:

Vice President

Gary J. Gorman is a Founding Partner of Regenerative Medical Solutions and Founder and Chairman of the Board of Gorman & Company, which he launched in 1984. Since then, he has grown it into one of the nation’s most active affordable housing developers, with a portfolio spanning thousands of completed units and billions of dollars in development activity nationwide. Mr. Gorman earned an Economics degree from the University of Wisconsin (1977) and a J.D. from the UW Law School (1980), practicing real estate and securities law in Madison before founding Gorman & Company.

Gary J. Gorman

Founding Partner

Learn More About Regenerative Medical Solutions

RMS’s leadership team is supported by a group of expert scientific and industry advisors. Read more about our advisors, or contact us to find out more about our work.